According to her, information about a shortage of the drug containing vitamin K1 in maternity hospitals in Kyrgyzstan has appeared on Threads. This drug is administered to newborns to prevent hemorrhagic disease of the newborn.
The user mentioned: "There is no 'Konakion' in the maternity hospitals of Kyrgyzstan. Many are looking for it in mothers' groups, as this is a vital injection for newborns. How is it possible that it is not available? Who allowed this situation? Why is there no emergency import? Why is this not being discussed publicly?"
The editorial office of Kaktus.media requested a comment from the state enterprise "Kyrgyzpharmacy" on this issue.
Representatives of the enterprise reported that procurement is carried out based on international non-proprietary names (INN) based on requests from healthcare organizations approved by the Ministry of Health.
"At the moment, in response to incoming requests regarding the availability of the drug 'Phytomenadione' (INN – 'Phytomenadione', trade name – 'Konakion'), the state enterprise 'Kyrgyzpharmacy' confirms that there is no shortage of drugs based on 'Phytomenadione' in the maternity institutions of the republic. Medicines of this group are available at the central warehouse and are supplied to medical organizations according to approved requests and delivery schedules," the press service added.
The photo on the main page is illustrative: thehealthyhomeeconomist.com.
